Prednisone and deflazacort in duchenne muscular dystrophy

Do they play a different role in child behavior and perceived quality of life?

Susan Sienko, Cathleen Buckon, Eileen Fowler, Anita Bagley, Loretta Staudt, Mitell Sison-Williamson, Kathy Zebracki, Craig M McDonald, Michael Sussman

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The aim of this study was to determine whether prednisone and deflazacort play a different role in child behavior and perceived health related psychosocial quality of life in ambulant boys with Duchenne Muscular Dystrophy. As part of a prospective natural-history study, parents of sixty-seven ambulant boys with DMD (27 taking prednisone, 15 taking deflazacort, 25 were steroid naïve) completed the Child Behavior Checklist (CBCL) for assessment of behavioral, emotional and social problems and both parents and boys with DMD completed the PedsQL™4.0 generic core scale short form. Boys with DMD had higher rates of general behavioral problems than age-matched peers. No significant differences were found among the groups for any of the CBCL syndrome scales raw scores, including internalizing and externalizing behaviors; however, on average boys taking deflazacort demonstrated more withdrawn behaviors than those taking prednisone, while on average the boys taking prednisone demonstrated more aggressive behaviors than boys taking deflazacort. Age, internalizing and externalizing behaviors accounted for 39 and 48% of the variance in psychosocial quality of life for both parents and boys with DMD, respectively. Overall, the use of steroids was not associated with more behavioral problems in boys with DMD. As behavior played a significant role in psychosocial quality of life, comprehensive assessment and treatment of behavioral problems is crucial in this population.

Original languageEnglish (US)
JournalPLoS Currents
Volume8
Issue numberMuscularDystrophy
StatePublished - 2016

Fingerprint

Duchenne Muscular Dystrophy
Child Behavior
Prednisone
Quality of Life
Parents
Checklist
Steroids
deflazacort
Social Problems
Natural History
Problem Behavior

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Sienko, S., Buckon, C., Fowler, E., Bagley, A., Staudt, L., Sison-Williamson, M., ... Sussman, M. (2016). Prednisone and deflazacort in duchenne muscular dystrophy: Do they play a different role in child behavior and perceived quality of life? PLoS Currents, 8(MuscularDystrophy).

Prednisone and deflazacort in duchenne muscular dystrophy : Do they play a different role in child behavior and perceived quality of life? / Sienko, Susan; Buckon, Cathleen; Fowler, Eileen; Bagley, Anita; Staudt, Loretta; Sison-Williamson, Mitell; Zebracki, Kathy; McDonald, Craig M; Sussman, Michael.

In: PLoS Currents, Vol. 8, No. MuscularDystrophy, 2016.

Research output: Contribution to journalArticle

Sienko, S, Buckon, C, Fowler, E, Bagley, A, Staudt, L, Sison-Williamson, M, Zebracki, K, McDonald, CM & Sussman, M 2016, 'Prednisone and deflazacort in duchenne muscular dystrophy: Do they play a different role in child behavior and perceived quality of life?', PLoS Currents, vol. 8, no. MuscularDystrophy.
Sienko S, Buckon C, Fowler E, Bagley A, Staudt L, Sison-Williamson M et al. Prednisone and deflazacort in duchenne muscular dystrophy: Do they play a different role in child behavior and perceived quality of life? PLoS Currents. 2016;8(MuscularDystrophy).
Sienko, Susan ; Buckon, Cathleen ; Fowler, Eileen ; Bagley, Anita ; Staudt, Loretta ; Sison-Williamson, Mitell ; Zebracki, Kathy ; McDonald, Craig M ; Sussman, Michael. / Prednisone and deflazacort in duchenne muscular dystrophy : Do they play a different role in child behavior and perceived quality of life?. In: PLoS Currents. 2016 ; Vol. 8, No. MuscularDystrophy.
@article{edcd93c55e1042769d703976a1f8b789,
title = "Prednisone and deflazacort in duchenne muscular dystrophy: Do they play a different role in child behavior and perceived quality of life?",
abstract = "The aim of this study was to determine whether prednisone and deflazacort play a different role in child behavior and perceived health related psychosocial quality of life in ambulant boys with Duchenne Muscular Dystrophy. As part of a prospective natural-history study, parents of sixty-seven ambulant boys with DMD (27 taking prednisone, 15 taking deflazacort, 25 were steroid na{\"i}ve) completed the Child Behavior Checklist (CBCL) for assessment of behavioral, emotional and social problems and both parents and boys with DMD completed the PedsQL™4.0 generic core scale short form. Boys with DMD had higher rates of general behavioral problems than age-matched peers. No significant differences were found among the groups for any of the CBCL syndrome scales raw scores, including internalizing and externalizing behaviors; however, on average boys taking deflazacort demonstrated more withdrawn behaviors than those taking prednisone, while on average the boys taking prednisone demonstrated more aggressive behaviors than boys taking deflazacort. Age, internalizing and externalizing behaviors accounted for 39 and 48{\%} of the variance in psychosocial quality of life for both parents and boys with DMD, respectively. Overall, the use of steroids was not associated with more behavioral problems in boys with DMD. As behavior played a significant role in psychosocial quality of life, comprehensive assessment and treatment of behavioral problems is crucial in this population.",
author = "Susan Sienko and Cathleen Buckon and Eileen Fowler and Anita Bagley and Loretta Staudt and Mitell Sison-Williamson and Kathy Zebracki and McDonald, {Craig M} and Michael Sussman",
year = "2016",
language = "English (US)",
volume = "8",
journal = "PLoS Currents",
issn = "2157-3999",
publisher = "Public Library of Science",
number = "MuscularDystrophy",

}

TY - JOUR

T1 - Prednisone and deflazacort in duchenne muscular dystrophy

T2 - Do they play a different role in child behavior and perceived quality of life?

AU - Sienko, Susan

AU - Buckon, Cathleen

AU - Fowler, Eileen

AU - Bagley, Anita

AU - Staudt, Loretta

AU - Sison-Williamson, Mitell

AU - Zebracki, Kathy

AU - McDonald, Craig M

AU - Sussman, Michael

PY - 2016

Y1 - 2016

N2 - The aim of this study was to determine whether prednisone and deflazacort play a different role in child behavior and perceived health related psychosocial quality of life in ambulant boys with Duchenne Muscular Dystrophy. As part of a prospective natural-history study, parents of sixty-seven ambulant boys with DMD (27 taking prednisone, 15 taking deflazacort, 25 were steroid naïve) completed the Child Behavior Checklist (CBCL) for assessment of behavioral, emotional and social problems and both parents and boys with DMD completed the PedsQL™4.0 generic core scale short form. Boys with DMD had higher rates of general behavioral problems than age-matched peers. No significant differences were found among the groups for any of the CBCL syndrome scales raw scores, including internalizing and externalizing behaviors; however, on average boys taking deflazacort demonstrated more withdrawn behaviors than those taking prednisone, while on average the boys taking prednisone demonstrated more aggressive behaviors than boys taking deflazacort. Age, internalizing and externalizing behaviors accounted for 39 and 48% of the variance in psychosocial quality of life for both parents and boys with DMD, respectively. Overall, the use of steroids was not associated with more behavioral problems in boys with DMD. As behavior played a significant role in psychosocial quality of life, comprehensive assessment and treatment of behavioral problems is crucial in this population.

AB - The aim of this study was to determine whether prednisone and deflazacort play a different role in child behavior and perceived health related psychosocial quality of life in ambulant boys with Duchenne Muscular Dystrophy. As part of a prospective natural-history study, parents of sixty-seven ambulant boys with DMD (27 taking prednisone, 15 taking deflazacort, 25 were steroid naïve) completed the Child Behavior Checklist (CBCL) for assessment of behavioral, emotional and social problems and both parents and boys with DMD completed the PedsQL™4.0 generic core scale short form. Boys with DMD had higher rates of general behavioral problems than age-matched peers. No significant differences were found among the groups for any of the CBCL syndrome scales raw scores, including internalizing and externalizing behaviors; however, on average boys taking deflazacort demonstrated more withdrawn behaviors than those taking prednisone, while on average the boys taking prednisone demonstrated more aggressive behaviors than boys taking deflazacort. Age, internalizing and externalizing behaviors accounted for 39 and 48% of the variance in psychosocial quality of life for both parents and boys with DMD, respectively. Overall, the use of steroids was not associated with more behavioral problems in boys with DMD. As behavior played a significant role in psychosocial quality of life, comprehensive assessment and treatment of behavioral problems is crucial in this population.

UR - http://www.scopus.com/inward/record.url?scp=85010807521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010807521&partnerID=8YFLogxK

M3 - Article

VL - 8

JO - PLoS Currents

JF - PLoS Currents

SN - 2157-3999

IS - MuscularDystrophy

ER -